[ad_1] Drug firm Jubilant Pharmova Ltd on Wednesday (March 12) said its subsidiary, Jubilant Cadista Pharmaceuticals Inc., has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its solid oral formulations facility in Salisbury, Maryland. “…we are pleased to inform that the […]
Jubilant Pharmova clears FDA inspection of Washington facilities – CNBC TV18
[ad_1] Drug firm Jubilant Pharmova Ltd on Thursday (September 26) announced the successful completion of an audit by the United States Food and Drug Administration (FDA) of its subsidiary Jubilant HollisterStier LLC’s facilities in Spokane, Washington. “Jubilant Pharmova Limited today announced that the United States Food and Drug Administration (USFDA) has concluded an audit of […]